Tolgay Tuyan Ilhan

Tolgay Tuyan Ilhan

Auto-generated profile, based on publicly available information

Tolgay Tuyan Ilhan

Department of Obstetrics and Gynecology, Faculty of Medicine, Mersin University, 33110 Mersin, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
GÜGörkem ÜLGER
Görkem ÜLGER
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
KAKasim AKAY
Kasim AKAY
HYHAMZA YILDIZ
HAMZA YILDIZ
AYAli Yildizbakan
Ali Yildizbakan
HAHakan Aytan
Hakan Aytan
The coexistence of adenomyosis and cancer of the endometrium has attracted heightened scrutiny, leading to inquiries regarding their possible interactions and clinical ramifications. This study sought to assess the influence of adenomyosis on tumor features and survival outcomes in patients with endometrioid-type endometrial carcinoma. A retrospective cohort analysis was performed on 422 patients who underwent surgical intervention for endometrioid-type endometrial carcinoma. The cohort was categorized into two groups according to the presence or absence of adenomyosis. Clinical and pathological data were gathered and evaluated to compare tumor features and survival outcomes between the two cohorts. Adenomyosis was present in 144 (34.1%) patients. Patients in the adenomyosis group demonstrated significantly higher gravidity and parity compared to those without adenomyosis. Lymphovascular space invasion was detected in 8.3% of the adenomyosis group compared to 17.6% in the non-adenomyosis group (a 53% reduction, p = 0.010). Similarly, rates of myometrial invasion (81.3% vs. 65.5%, p = 0.001), cervical stromal invasion (9.0% vs. 14.1%, p = 0.005), and lymph node metastasis (4.2% vs. 14.4%, p = 0.001) were significantly lower in patients with adenomyosis. The five-year overall survival rate was 90.8% in the adenomyosis group and 87.1% in the non-adenomyosis group, although this difference was not statistically significant (p = 0.689). This study demonstrates that adenomyosis is associated with a significant reduction in aggressive tumor characteristics such as myometrial invasion, lymphovascular space involvement, and lymph node metastasis in patients with endometrioid-type endometrial cancer. These findings emphasize that adenomyosis may be a potential protective factor in endometrial cancer prognosis and should be considered in clinical risk assessment. Prospective studies with larger cohorts are needed to confirm the long-term effects of adenomyosis on survival.

29 July 2023 in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Verified
Journal Article
Closed access
SESeval Yılmaz Ergani
Seval Yılmaz Ergani
TITolgay Tuyan İlhan
Tolgay Tuyan İlhan
BÇBetül Tokgöz Çakır
Betül Tokgöz Çakır
BBBurak Bayraktar
Burak Bayraktar
MBMevlut Bucak
Mevlut Bucak
YEYaprak Engin-Üstün
Yaprak Engin-Üstün
AIM: We investigated whether measurement of triglyceride/glucose index (TyG) and triglyceride/HDL-cholesterol ratio (TG /HDL-c) in the first trimester can predict gestational diabetes mellitus (GDM). MATERIAL AND METHOD: Twenty-five patients with GDM and 52 women without GDM with normal glycemic control during pregnancy were included in the study as a control group. Both insulin-controlled diabetes and diet-controlled diabetes were included in the diagnosis of GDM. Fasting glucose and plasma lipid profiles including TG, HDL-c, TyG index, and TG /HDL-c measured in the first trimester were analyzed. RESULTS: Triglyceride values (mean 133±40 mg/dL in the gestational diabetes group, 100±54 mg/dL in the control group), TyG index (15.0±8.9 in the mean gestational diabetes group, 8.8±5.0 in the control group), and TG/HDL-C ratio (mean 3.3±2.6 in the gestational diabetes group and 1.9±2.6 in the control group) was found to be significantly higher in the GDM group (p=0.01, p=0.01, p=0.01, respectively). The optimal cutoff value for TyG index was 10.4, sensitivity was 76%, specificity was 77%, and area under the receiver characteristic curve (AUC) was 0.765 to predict GDM (p < 0.001). The optimal cutoff value for the TG /HDL-C ratio was 2.3, sensitivity was 76%, specificity was 69, AUC 0.697 to predict GDM (p=0.005). CONCLUSION: TyG and TG/HDL-C ratio measured in the first trimester are thought to predict GDM better than fasting plasma glucose. AMAÇ: Birinci trimesterde trigliserit/glukoz indeksi (TyG) ve trigliserid/HDL-kolesterol oranı (TG /HDL-c) ölçümünün gestasyonel diyabetes mellitusu (GDM) tahmin edip edemeyeceğini araştırdık. GEREÇ VE YÖNTEM: Gebelikte GDM'li 25 hasta ve glisemik kontrolü normal olan GDM'siz 52 hasta kontrol grubu olarak çalışmaya alındı. GDM tanısına hem insülin kontrollü diyabet hem de diyet kontrollü diyabet dahil edildi. İlk trimesterde ölçülen TG, HDL-c, TyG indeksi ve TG /HDL-c'yi içeren açlık glukoz ve plazma lipid profilleri analiz edildi. BULGULAR: Trigliserit değerleri (ortalama gestasyonel diabetes grubunda 133±40 mg/dL, kontrol grubunda 100±54 mg/dL), TyG indeksi (ortalama gestasyonel diabetes grubunda 15,0±8,9, kontrol grubunda 8,8±5,0) ve TG/HDL-K oranı (ortalama gestasyonel diabetes grubunda 3,3±2,6 kontrol grubunda 1,9±2,6) GDM grubunda anlamlı olarak daha yüksek bulundu(sırasıyla p=0.01, p=0.01, p=0.01) GDM'yi öngörmek için TyG indeksi için optimal kesme değeri 10,4, duyarlılık %76, özgüllük %77 ve ROC analizinde eğri altında kalan alan (AUC) 0,765 idi (p < 0,001). GDM'yi öngörmek için TG/HDL-K oranı için optimal kesme değeri 2,3, duyarlılık %76, özgüllük 69, AUC 0,697 idi (p=0,005). SONUÇ: İlk trimesterde ölçülen TyG ve TG/HDL-C oranının GDM'yi açlık plazma glukozundan daha iyi öngördüğü düşünülmektedir.

19 June 2026 in Medicina
Verified
Journal Article
Open access
PDF file
KAKasim AKAY
Kasim AKAY
GÜGörkem ÜLGER
Görkem ÜLGER
HYHAMZA YILDIZ
HAMZA YILDIZ
ZKZeynep Küçükolcay
Zeynep Küçükolcay
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
HAHakan Aytan
Hakan Aytan
Background and Objectives: The relationship between preoperative inflammatory markers and lymphovascular space invasion (LVSI) in endometrioid-type endometrial cancer (EC) remains incompletely defined and warrants evaluation using robust statistical methods. This study aimed to evaluate the independent association of preoperative inflammatory markers, analyzed strictly as continuous variables, with the presence of LVSI, and to develop a refined predictive nomogram adjusted for established clinical confounders. Materials and Methods: Data from 156 patients who underwent standard staging surgery for endometrioid-type EC were retrospectively analysed. To preserve statistical power and avoid structural artifacts from data forcing, preoperative glucose-to-lymphocyte ratio (GLR), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) were modeled on their original continuous scale. Multivariable logistic regression analysis was performed to identify independent risk factors for LVSI, adjusting for patient age and maximum tumor diameter. Internal validation was conducted using bootstrap resampling (1000 iterations). Results: In the multivariable logistic regression model, continuous PLR emerged as a significant independent risk factor for the presence of LVSI (adjusted OR: 1.013 per 1-unit increase, 95% CI: 1.001–1.024; p = 0.033). Among clinical parameters, maximum tumor diameter demonstrated the strongest independent association with LVSI (adjusted OR: 1.595 per 1 cm increase, 95% CI: 1.211–2.099; p = 0.001). Continuous NLR (p = 0.513) and GLR (p = 0.545) did not retain statistical significance due to overlapping explanatory variance and shared hematological components. The optimized 3-variable nomogram (PLR, tumor size, and age) demonstrated an apparent C-index of 0.816 (95% bootstrap CI: 0.719–0.920) and a robust optimism-corrected C-index of 0.794. The bootstrap-corrected calibration slope was 0.909, and Decision Curve Analysis (DCA) demonstrated a positive net clinical benefit across clinically relevant threshold probabilities. Conclusions: Preoperative PLR, evaluated as a continuous parameter, provides a statistically stable framework for preoperative risk stratification in endometrioid EC. When integrated with tumor size and age, the proposed nomogram demonstrates promising discriminative performance and potential clinical utility pending external validation for predicting LVSI. However, given the limited number of LVSI-positive events (n = 17), these findings should be regarded as exploratory and hypothesis-generating and require external validation before clinical use.

30 September 2024 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
TITolgay Tuyan İlHan
Tolgay Tuyan İlHan
GÜGörkem ÜLGER
Görkem ÜLGER
AYAli Yıldızbakan
Ali Yıldızbakan
Mürşide ÇEVİKOĞLU KILLIMürşide ÇEVİKOĞLU KILLI
Mürşide ÇEVİKOĞLU KILLI
HYHAMZA YILDIZ
HAMZA YILDIZ
Aim: The objective of our study was to evaluate the preoperative circumstances, treatments, and postoperative states of patients at our university hospital. Materials and Methods: This retrospective study used the Mersin University Hospital's gynecological oncology clinic database. Patient age, menopausal status, preoperative tumor markers, and preoperative ultrasonography features were collected from the hospital databases. After the initial procedure, information regarding the surgical method, histological classification, stage at the time of diagnosis, size of the tumor, status of the lymph nodes, and the ultimate pathological diagnosis were collected. Results: This study has a cohort of 84 patients who underwent surgery between 2007 and 2023. The study groups had a median age of 41.5, ranging from 15 to 88. Out of the total patients, 71.4% were in the premenopausal stage. Final pathology revealed the presence of a malignant tumor in 10 patients, accounting for 11.9% of the total. Out of the total number of patients, six had serous tumors, while four had mucinous tumors. Out of the 83 people, a recurrence of the condition was found in 3, indicating a rate of 3.6%. The mean duration of progression-free survival for these individuals was 19 months. Only individuals in the early stage of the disease experienced a recurrence, and two exhibited micropapillary variants. Conclusion: Ultimately, BOTs have a highly favorable prognosis. Patients who meet the criteria might consider undergoing fertility-preserving surgical procedures.

19 May 2024 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
Mürşide ÇEVİKOĞLU KILLIMürşide ÇEVİKOĞLU KILLI
Mürşide ÇEVİKOĞLU KILLI
AYAli Yıldızbakan
Ali Yıldızbakan
GÜGörkem ÜLGER
Görkem ÜLGER
TITolgay Tuyan İlhan
Tolgay Tuyan İlhan
Amaç: İleri evre over malignitelerinde cerrahi sonrası morbidite nedenlerini, hastanede yatışla ilişkili risk faktörlerini değerlendirmek. Gereçler ve Yöntem: Eylül 2018–Aralık 2023 tarihleri arasında Mersin Üniversitesi Jinekolojik Onkoloji Bilim Dalı’na başvuran evre III over malignitesi tanısı olan 88 hasta çalışmaya dahil edildi. Hastaların demografik bilgileri, kanserin histolojik tipleri, tedavinin yönetimi ve sitoredüktif cerrahinin kapsamı, komplikasyonlar ve yönetimi, yoğun bakım ihtiyacı, morbidite ve erken dönem yatış süreleri, hastaneye yeniden kabuller ve müdahaleler değerlendirilmiştir. Bulgular: Primer sitoredüktif cerrahi (PSC) sonrası hastaların %70.6’sında, nüks sonrası cerrahilerin %74.1’inde, neoadjuvan kemoterapi sonrası interval sitoredüksiyon (NAKS-IS) yapılan hastaların %70.4’ünde komplet sitoredüksiyon sağlandı. Postoperatif erken dönemde morbiditenin en sık nedenleri sırası ile %17 yara yeri enfeksiyonu, %10.2 atelektazi, bulantı-ileus %9.1 idi. Yara yeri enfeksiyonu, atelektazi, ileus, tromboemboli görülme sıklığı açısından istatistiki olarak guruplar arası fark yoktu(p=0.537). Postoperatif dönemde yatış süresi ve 2. basamak yoğun bakım ihtiyacı açısından yönetimler arası fark yoktu(p>0.05). Postoperatif hospitalizasyonun en sık nedeni yara yeri enfeksiyonudur. Sonuç: Tedavi yönetimlerimiz arasında ve sitoredüksiyon başarıları açısından fark yoktu(p>0.05). NAKS-IS’in PSC’ye göre cerrahi süresi, yoğun bakım ihtiyacı, hastanede kalış süresi bakımından avantajlı bulunmuştur. Sitoredüksiyon oranları ve postoperatif komplikasyonlar açısından fark bulunmamıştır(p>0.05). Yara yeri enfeksiyonunun NAKS-IS te PSC’ye oranla fazla olma nedenini NAK bağlı sitopeni ile ilişkilendirebiliriz. PSC’de NAKS-IS’e kıyasla hızlı patoloji kullanımı, ameliyat süresi, postoperatif atelektazi ve ileus oranları artmıştır. Sitoredüktif cerrahi sonrası yara yeri enfeksiyonu, atelektazi, ileus ve tromboemboli açısından hastaların yakın takibi önemlidir.

14 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
GÜGörkem ÜLGER
Görkem ÜLGER
KAKasim AKAY
Kasim AKAY
HYHAMZA YILDIZ
HAMZA YILDIZ
PAPelin Aytan
Pelin Aytan
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
TITolgay Tuyan Ilhan
Tolgay Tuyan Ilhan
Background and Objectives: Peripheral blood indices have been proposed as prognostic biomarkers in endometrial cancer, but most reports include mixed histological subtypes, do not control for benign uterine pathology that independently alters hematological profiles, and evaluate these indices in isolation. We evaluated all three categories head-to-head in a histologically homogeneous endometrioid cohort and formally tested whether they add prognostic information beyond established clinicopathological variables. Materials and Methods: Of 195 patients operated for endometrioid-type endometrial cancer between 2018 and 2024, 142 were included; adenomyosis or leiomyoma on final histopathology, active infection and hematological disease were exclusion criteria. Fourteen preoperative blood-derived indices spanning the three categories were analyzed as continuous variables. A pre-specified clinical model (age category, grade, FIGO stage) was compared with models adding the biomarkers using likelihood-ratio tests, Harrell’s concordance index, time-dependent areas under the curve, bootstrap internal validation, and influence diagnostics. Results: Median follow-up was 52.5 months; 34 patients (23.9%) died and 5-year overall survival was 74.1%. None of the conventional inflammatory ratios were associated with survival (SII p = 0.893; all others p ≥ 0.26). In the multivariable model, histologic grade and NRBC% remained associated with survival (NRBC% HR 3.30 per 1%, 95% CI 1.09–9.97, p = 0.034). Adding NRBC% to the clinical model improved fit (likelihood-ratio p = 0.039) but not discrimination (ΔC 0.006, 95% CI −0.041 to 0.053, p = 0.814), and no index retained significance after Benjamini–Hochberg adjustment. The NRBC% association disappeared on dichotomization at the detection limit and could not be estimated once the five patients with values above 0.30% were excluded. Conclusions: In a predominantly early-stage endometrioid endometrial cancer cohort, preoperative blood-derived indices added no measurable discriminatory information beyond established pathological variables. The NRBC% association rests on very few observations at the upper end of its distribution and is hypothesis-generating only.